Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/30/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Stephen J. Chanock

Wrong Dr. Stephen J. Chanock?

Board Member

National Institutes of Health
31 Center Dr. MSC 2062 Building 31, Room B1-W30
Bethesda , Maryland 20892
United States

Company Description: The National Institutes of Health (NIH) - The Nation's Medical Research Agency - is comprised of 27 Institutes and Centers and is a component of the U. S....   more

Employment History

  • Division of Cancer Epidemiology and Genetics
    National Institutes of Health
  • Cancer Geneticist
    National Cancer Institute
  • Chief of Translational Genomics
    National Cancer Institute
  • Senior Principal Investigator
    National Cancer Institute
  • Chief of Laboratory
    NCI Core Genotyping Facility
  • Director In the Advanced Technology Center
    NCI Core Genotyping Facility
  • Senior Investigator
    NCI Core Genotyping Facility
  • Chief of the Laboratory of Translational Genomics
    U.S. National Cancer Institute
  • Head of the Genomic Variation Section
    U.S. National Cancer Institute
  • Senior Investigator
    U.S. National Cancer Institute
  • Director of the NCI Core Genetics Facility and Co-Director
  • Head of the Variation Section
  • Chief, Laboratory
    Translational Genomics
  • Member, Division
    Translational Genomics
  • Member, Division of Cancer Epidemiology and Genetics
    Translational Genomics

Board Memberships and Affiliations


  • MD
  • M.D.
126 Total References
Web References
Board of Directors | Special Love, 29 May 2014 [cached]
Dr. Stephen Chanock Director, Division of Cancer Epidemiology and Genetics
There is, however, no direct proof ... [cached]
There is, however, no direct proof that loss of Y sex chromosomes actually causes disease, cautions Stephen Chanock, a cancer geneticist at the National Cancer Institute in Bethesda, Maryland, who was not involved with the work.
Chanock agrees. "While the findings are intriguing," he says, "the associations between Y chromosome loss and shortened life span and disease risk do need to be confirmed in other large [long-term] studies."
"This is a very exciting and ..., 2 Aug 2012 [cached]
"This is a very exciting and interesting and, to be honest, important observation in the world of cancer susceptibility," says Stephen Chanock, the chief of translational genomics at the National Cancer Institute in Bethesda, Maryland, who was not involved in the study.
It's still unclear whether testicular cancer is more often caused by de novo mutations instead of inherited ones when compared with other cancer types, says Chanock. But the study provides vital clues about the risk factors for some cancers. "I suspect as we dig deeper into sequencing and family studies, we'll see more and more CNVs representing a portion of the genetic architecture that explains diseases," he says.
National Cancer Institute Purchases Production-Scale BeadLab From Illumina For Array-Based Genetic Analysis, 1 Sept 2005 [cached]
Under the guidance of Stephen J. Chanock, M.D., an NCI Senior Principal Investigator, the Institute will leverage the BeadLab and related SNP (single nucleotide polymorphism) genotyping solutions from Illumina for multi-phase projects designed to identify and validate cancer biomarkers, and then incorporate those biomarkers into a highly multiplexed SNP genotyping panel with predictive and pharmacogenomic value.
"Dr. Chanock and his research colleagues both inside and outside the National Cancer Institute are laying crucial groundwork for understanding a broad range of cancers," stated Jay Flatley, Illumina President and CEO.
TIGER 21 - Presenter Bio, 10 Mar 2014 [cached]
Stephen Chanock TIGER 21 - Presenter Bio MEMBER LOGIN
Stephen Chanock
Chief, Laboratory of Translational Genomics of National Cancer Institute
Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology and research training in molecular genetics at Boston Children's Hospital and the Dana-Farber Cancer Institute, Boston. Afterwards, he joined the National Cancer Institute, initially in the Pediatric Oncology Branch where he became a Senior Investigator. Several years ago he transitioned to the Division of Cancer Epidemiology and Genetics, where he has lead a highly productive program mapping cancer susceptibility genes. In 2001, he became director of the NCI Core Genotyping Facility and in 2005 he became co-leader of the Cancer Genetic Markers of Susceptibility (CGEMS) project. In 2007, he became the Chief of the newly formed Laboratory of Translational Genomics. Dr. Chanock has published nearly 600 peer review papers and recently received the prestigious Moyent and Rothschild Sabbatical Award at the Institute Curie in Paris, France.
Other People with the name "Chanock":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.